Hormonal therapy can successfully battle to relapse of a cancer of the prostate, steady before other kinds of treatment. This experimental prostate cancer treatment helps with struggle against a cancer which comes back after castration.
Preliminary researches allow to assume, that new hormonal therapy can become the weapon in struggle against a cancer of a prostate which comes back even after surgical excision of testicles. For today two stages of research from three so while early to speak about full success are finished. And about, whether the given kind of therapy approval of the authorities will meet with.

Now the experimental hormonal therapy known as MDV3100, passes check as a new way of treatment of the form of a cancer of the prostate steady against castration. On it it is informed in magazine The Lancet from April, 14th. As is known, Testosteron-Depotum for growth is required to a prostate cancer, and excision of testicles in addition with other medicinal interventions suppresses ability of a body to make this hormone.

Existing treatment kills some cancer cells, and others survive, though become inactive. Alas, after a while their "hibernation" can come to an end, and then there will be a cancer relapse. These remained cells have ability to live without serious injections of Testosteron-Depotum, therefore the given cancer and name steady against castration.
Scientists from oncologic centre Memorial Sloan-Kettering in New York have checked up therapy MDV3100 on 140 patients having the above-named form of a cancer. Dosages varied from 30 to 600 mg a day to find as much as possible admissible concentration. It has been defined in 240 mg. At a number of patients the positive effect, thanks to new hormonal therapies has been fixed steadily. Ahead the third stage, on which a hormonal medicine will compare on degree of efficiency with placebo to find out, how much it is capable to prolong a life the patient with finishing stages of a cancer of a prostate.